Drugs / CAR1922T2 T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06879262 | Feb 2026 → Feb 2028 expected | non-Hodgkin lymphoma | Tongji Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR1922T2 T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06879262 ↗ |
| Modality | Cell therapy | “CAR-T cell therapy” NCT06879262 ↗ |